Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting the endocannabinoid system in treating brain disorders.

Ben A Bahr1, David A Karanian, Sagar S Makanji

  • 1Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA. Bahr@uconn.edu

Expert Opinion on Investigational Drugs
|March 22, 2006
PubMed
Summary

Cannabinoid research shows promise for treating neurodegenerative disorders by activating brain repair pathways. Enhancing natural endocannabinoids offers a therapeutic strategy for neuroprotection against CNS diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cannabinoid (CB) 1 receptor antagonists block fentanyl conditioned place preference but not fentanyl antinociception.

Drug and alcohol dependence·2026
Same author

Library Docking for Cannabinoid-2 Receptor Ligands.

Journal of medicinal chemistry·2026
Same author

Library docking for Cannabinoid-2 Receptor ligands.

bioRxiv : the preprint server for biology·2026
Same author

Dopamine, γ-aminobutyric acid, and glutamate balance in the nucleus accumbens shell: Differential effects of cannabinoid 1 receptor agonists Δ<sup>9</sup>-Tetrahydrocannabinol, AM11101, and AM8936.

Neuropharmacology·2026
Same author

Ginseng extract improves synaptic resiliency: A key factor for healthy cognitive aging.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Effects of the neutral CB1 receptor antagonist AM6527 on spontaneous, consummatory, and motivated behavior in mice.

Psychopharmacology·2025

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Cannabinoid research is increasingly focused on therapeutic applications for human diseases.
  • Studies suggest cannabinoids offer neuroprotection against various neurodegenerative disorders.
  • The endocannabinoid system, involving endogenous ligands like anandamide and 2-arachidonoyl glycerol, plays a role in neuronal repair and cell maintenance.

Purpose of the Study:

  • To review recent studies on the endocannabinoid system's role in neuroprotection.
  • To highlight therapeutic strategies targeting endocannabinoid availability for promoting endogenous repair signalling.
  • To explore the potential of modulating endocannabinoid deactivation processes for CNS disorder treatment.

Main Methods:

  • Review of recent scientific literature on cannabinoid research and neuroprotection.

Related Experiment Videos

  • Analysis of studies focusing on the modulation of endocannabinoid deactivation pathways.
  • Examination of the role of enzymes like fatty acid amide hydrolase and monoacylglycerol lipase, and transport systems in endocannabinoid activity.

    • Main Results:

    • Endocannabinoids are released in response to pathogenic events, acting as a compensatory repair mechanism.
    • Inhibiting endocannabinoid deactivation (e.g., via fatty acid amide hydrolase or monoacylglycerol lipase inhibitors) enhances neuroprotective effects.
    • Targeting endocannabinoid transport and degradation processes can effectively leverage cannabinergic responses for neuroprotection.

    Conclusions:

    • The endocannabinoid system is implicated in neuroprotection across various central nervous system (CNS) disorders.
    • Modulating endocannabinoid levels by inhibiting their breakdown is a promising therapeutic strategy.
    • Further research into enhancing endogenous repair mechanisms via the endocannabinoid system could lead to novel treatments for neurological diseases.